The United Laboratories International Holdings Limited

SEHK:3933 Stock Report

Market Cap: HK$18.7b

United Laboratories International Holdings Balance Sheet Health

Financial Health criteria checks 5/6

United Laboratories International Holdings has a total shareholder equity of CN¥17.5B and total debt of CN¥5.0B, which brings its debt-to-equity ratio to 28.5%. Its total assets and total liabilities are CN¥30.9B and CN¥13.4B respectively. United Laboratories International Holdings's EBIT is CN¥2.2B making its interest coverage ratio -26.8. It has cash and short-term investments of CN¥10.6B.

Key information

28.49%

Debt to equity ratio

CN¥4.98b

Debt

Interest coverage ratio-26.8x
CashCN¥10.61b
EquityCN¥17.48b
Total liabilitiesCN¥13.43b
Total assetsCN¥30.90b

Recent financial health updates

Recent updates

Analysis Article Mar 27

The United Laboratories International Holdings Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

The United Laboratories International Holdings Limited ( HKG:3933 ) missed earnings with its latest full-year results...
Analysis Article Feb 09

The United Laboratories International Holdings Limited (HKG:3933) Looks Inexpensive But Perhaps Not Attractive Enough

With a price-to-earnings (or "P/E") ratio of 7.5x The United Laboratories International Holdings Limited ( HKG:3933...
Analysis Article Oct 28

Little Excitement Around The United Laboratories International Holdings Limited's (HKG:3933) Earnings

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 13x, you may consider...
Analysis Article Oct 06

United Laboratories International Holdings' (HKG:3933) Profits May Not Reveal Underlying Issues

The recent earnings posted by The United Laboratories International Holdings Limited ( HKG:3933 ) were solid, but the...
Analysis Article Jun 30

United Laboratories International Holdings (HKG:3933) Has Affirmed Its Dividend Of CN¥0.438

The United Laboratories International Holdings Limited's ( HKG:3933 ) investors are due to receive a payment of...
Analysis Article Jun 11

Optimistic Investors Push The United Laboratories International Holdings Limited (HKG:3933) Shares Up 25% But Growth Is Lacking

The United Laboratories International Holdings Limited ( HKG:3933 ) shareholders would be excited to see that the share...
Analysis Article Apr 23

United Laboratories International Holdings (HKG:3933) Has A Pretty Healthy Balance Sheet

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Mar 28

Earnings Miss: The United Laboratories International Holdings Limited Missed EPS By 9.8% And Analysts Are Revising Their Forecasts

It's shaping up to be a tough period for The United Laboratories International Holdings Limited ( HKG:3933 ), which a...
Analysis Article Mar 24

What The United Laboratories International Holdings Limited's (HKG:3933) 26% Share Price Gain Is Not Telling You

The United Laboratories International Holdings Limited ( HKG:3933 ) shares have continued their recent momentum with a...
Analysis Article Feb 05

Benign Growth For The United Laboratories International Holdings Limited (HKG:3933) Underpins Its Share Price

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 11x, you may consider...
Analysis Article Jan 10

Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analysis Article Nov 11

These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Oct 23

The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market

The United Laboratories International Holdings Limited ( HKG:3933 ) shareholders have had their patience rewarded with...
Analysis Article Aug 30

Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article Feb 29

Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified

The United Laboratories International Holdings Limited ( HKG:3933 ) shareholders would be excited to see that the share...
Analysis Article Jan 04

The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement

The United Laboratories International Holdings Limited's ( HKG:3933 ) price-to-earnings (or "P/E") ratio of 5.3x might...
Analysis Article Dec 14

United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Nov 26

With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Analysis Article Aug 31

Is United Laboratories International Holdings (HKG:3933) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Aug 10

Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article Dec 23

United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Oct 19

Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of The United...

Financial Position Analysis

Short Term Liabilities: 3933's short term assets (CN¥18.5B) exceed its short term liabilities (CN¥10.1B).

Long Term Liabilities: 3933's short term assets (CN¥18.5B) exceed its long term liabilities (CN¥3.3B).


Debt to Equity History and Analysis

Debt Level: 3933 has more cash than its total debt.

Reducing Debt: 3933's debt to equity ratio has increased from 25.7% to 28.5% over the past 5 years.

Debt Coverage: 3933's debt is well covered by operating cash flow (75.3%).

Interest Coverage: 3933 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/15 09:58
End of Day Share Price 2026/05/15 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

The United Laboratories International Holdings Limited is covered by 27 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ying ShaoBofA Global Research
Yue-Kwong LuiCGS International
Jing QiangChina International Capital Corporation Limited